With the death of Pope Francis, the world loses not only a church leader but also a moral compass
Latest editorial
Patents: how the profit machine costs lives
Despite miraculous trial results showing new treatment could halt transmission, corporate greed and patent laws condemn millions to preventable infection and death, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT
LINING THEIR POCKETS: Gilead Sciences HQ in Foster City, California; (insert) Descovy used for HIV prevention through pre-exposure prophylaxis
LYNNE WALSH previews the Bristol Radical History Conference this weekend
Keir Starmer’s £120 million to Sudan cannot cover the government’s complicity in the RSF genocide or atone for the long shadow of British colonialism and imperialism, writes CLAUDIA WEBBE
Join the traditional march from Clerkenwell Green, which will bring together countless international workers’ organisations in a statement against the far right
Ecuador’s election wasn’t free — and its people will pay the price under President Noboa
Mountains of research show that hardcore material harms children, yet there are still no simple measures in place
We face austerity, privatisation, and toxic influence. But we are growing, and cannot be beaten
DECIDING a particular year when a scientific discovery or advance took place is often an arbitrary decision. Archimedes is said to have leapt from his bathtub and shouted “Eureka!” when he realised that the volume of any object, no matter how complicated, could be found by placing the object in water and measuring the volume of water it displaces.
But even that eureka moment is of dubious authenticity. It is rare for scientific research to advance in a glorious instant of revelation.
So when the journal Science named the HIV/AIDS drug lenacapavir as its “breakthrough of the year,” it shouldn’t be surprising that its story began far earlier.
More from this author
Science has always been mixed up with money and power, but as a decorative facade for megayachts, it risks leaving reality behind altogether, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT
A small Japanese trial has reported some positive results for stem cell therapy to treat spinal-cord injuries
Man-made canals like Panama and Suez face unprecedented challenges from extreme weather patterns and geopolitical tensions that reveal the fragility of our global trade networks, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT
It’s sunny times for the solar industry which is expected to continue to grow rapidly — but there are still major environmental issues with how solar cells are made, explain ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT
